2025-04-01 02:50:59
Latest Post
Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks
ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited
AGI Greenpac Ltd approves ~ Rs. 700 crore capex
NHPC Ltd updates on 300 MW Bikaner Solar Power Project
Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd
Stock Report
Gujarat Themis Biosyn Ltd Q2FY23 PAT higher at Rs. 18.69 crores
Posted On : 2022-11-07 12:35:39( TIMEZONE : IST )
GUJARAT THEMIS BIOSYN LTD. has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 49.0873 crores during the period ended September 30, 2022 as compared to Rs. 46.3669 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 18.6990 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 17.7702 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 12.87 for the period ended September 30, 2022 as compared to Rs. 12.23 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 49.0873 crs | ₹46.3669 crs |  5.87% |
| Net Profit | ₹18.6990 crs | ₹17.7702 crs | 5.23% |
| EPS | ₹12.87 | ₹12.23 | 5.23% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 49.0873 crores during the period ended September 30, 2022 as compared to Rs.35.7613 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.18.6990 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.13.7920 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.12.87 for the period ended September 30, 2022 as compared to Rs.9.49 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 49.0873 crs | ₹35.7613 crs | 37.26% |
| Net Profit | ₹18.6990 crs | ₹13.7920 crs | 35.58% |
| EPS | ₹12.87 | ₹9.49 | 35.62% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.95.4542 crores during the 6 Months period ended September 30, 2022 as compared to Rs.69.3348 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.36.4692 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.26.7147 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.25.10 for the 6 Months period ended September 30, 2022 as compared to Rs.18.39 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹95.4542 crs | ₹69.3348 crs | 37.67% |
| Net Profit | ₹36.4692 crs | ₹26.7147 crs | 36.51% |
| EPS | ₹25.10 | ₹18.39 | 36.49% |
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs. 738.65 as compared to the previous close of Rs. 752.40. The total number of shares traded during the day was 7745 in over 396 trades.
The stock hit an intraday high of Rs. 763.00 and intraday low of 735.00. The net turnover during the day was Rs. 5764552.00.
